글로벌 일회용 인슐린 펌프 시장 규모, 점유율 및 추세 분석 보고서 – 산업 개요 및 2031년까지의 예측

일회용 인슐린 펌프 시장 분석  

일회용 인슐린 펌프 시장은 당뇨병 유병률 증가와 혁신적이고 사용자 친화적인 기기에 대한 수요 증가로 인해 상당한 성장을 경험하고 있습니다. 2030년까지 전 세계 당뇨병 인구가 6억 4,300만 명에 달할 것으로 예상됨에 따라 효과적인 인슐린 투여 시스템에 대한 필요성이 그 어느 때보다 절실합니다. 최근 시장에서의 발전에는 포도당 관리를 개선하고 사용자에게 실시간 데이터를 제공하는 통합 지속적 포도당 모니터링(CGM) 시스템을 갖춘 고급 일회용 인슐린 펌프의 도입이 포함됩니다. 기업들은 편의성을 개선하고 당뇨병 관리의 부담을 줄이는 튜브리스 및 경량 모델과 같은 사용자 중심 설계에 집중하고 있습니다. 또한 최근 여러 첨단 제품에 대한 FDA 승인과 같은 새로운 일회용 인슐린 투여 시스템에 대한 규제 승인은 시장 접근성을 확대하고 소비자 신뢰를 높이고 있습니다. 기술 회사와 의료 서비스 제공자 간의 협력도 혁신을 가속화하여 더 나은 당뇨병 관리를 위한 모바일 애플리케이션과 연결되는 스마트 인슐린 펌프의 개발로 이어지고 있습니다. 당뇨병 관리에 대한 인식이 계속 높아짐에 따라 일회용 인슐린 펌프 시장은 견고한 성장을 향해 나아가 당뇨병 환자의 삶의 질을 향상시키고 있습니다.

일회용 인슐린 펌프 시장 규모

글로벌 일회용 인슐린 펌프 시장 규모는 2023년에 35억 7천만 달러로 평가되었으며, 2031년까지 65억 달러에 도달할 것으로 예상되며, 2024년에서 2031년까지의 예측 기간 동안 CAGR은 7.77%입니다. Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 세분화, 지리적 범위, 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 심층 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

일회용 인슐린 펌프 시장 동향

“ 스마트 기술 통합 증가”

일회용 인슐린 펌프 시장은 환자들이 당뇨병 관리를 위한 편리하고 비용 효율적인 솔루션을 찾으면서 인기를 얻고 있습니다. 시장에서 두드러지는 추세는 스마트 기술 통합으로의 전환이 증가하고 있으며, 이러한 기기의 기능과 사용자 경험이 향상되고 있습니다. 이러한 고급 인슐린 펌프는 이제 종종 무선 연결 기능을 갖추고 있어 환자가 스마트폰 애플리케이션을 통해 포도당 수치를 모니터링하고 인슐린 투여를 관리할 수 있습니다. 예를 들어, Omnipod DASH와 같은 기기는 실시간 데이터 추적 기능이 있는 튜브리스 디자인을 제공하여 환자의 준수와 사용 편의성을 개선함으로써 인기를 얻었습니다. 당뇨병 관리가 더욱 개인화됨에 따라 자동 인슐린 투여 및 의료 서비스 제공자와의 데이터 공유와 같은 고급 기능이 있는 일회용 인슐린 펌프에 대한 수요가 증가하고 있습니다. 이러한 추세는 당뇨병 환자에게 효과적이고 편리한 치료 옵션을 제공하는 데 있어 기술의 중요성이 커지고 있음을 보여줍니다.

보고서 범위 및 일회용 인슐린 펌프 시장 세분화  

Disposable Insulin Pumps Market Definition

Disposable insulin pumps are compact, portable devices designed to deliver precise doses of insulin to individuals with diabetes, they are designed for single-use and come pre-filled with insulin. These pumps often feature user-friendly interfaces and are equipped with technology to facilitate easy insulin administration, helping to manage blood glucose levels effectively. They may also include advanced functionalities, such as integration with continuous glucose monitoring systems, enabling real-time glucose tracking and automated insulin delivery. T Their ease of use and convenience make disposable insulin pumps a popular choice for patients looking for a straightforward way to manage their diabetes.

Disposable Insulin Pumps Market Dynamics

Drivers

• Rising Prevalence of Diabetes

The rising prevalence of diabetes is a significant driver for the disposable insulin pumps market, as the increasing global incidence of both type 1 and type 2 diabetes necessitates effective insulin delivery systems. According to the International Diabetes Federation, over 537 million adults were living with diabetes in 2021, and this number is projected to reach 783 million by 2045. This alarming trend underscores the urgent need for innovative diabetes management solutions, including disposable insulin pumps that offer convenience and precision in insulin delivery. As the population of diabetes patients continues to grow, particularly in regions such as Asia-Pacific where the prevalence is rapidly increasing, the demand for disposable insulin pumps is expected to expand significantly, creating lucrative opportunities for manufacturers and healthcare providers in this evolving market.

• Rising Global Aging Population

The global aging population significantly influences the demand for easy-to-use insulin delivery devices, as older adults are more prone to diabetes and its associated complications. According to the World Health Organization (WHO), the number of people aged 60 and older is expected to reach 2.1 billion by 2050, representing a substantial increase from 1 billion in 2019. Such demographic shift is accompanied by a higher prevalence of diabetes, with estimates suggesting that approximately 10% of older adults are living with the condition. As managing diabetes becomes increasingly complex with age, there is a growing need for user-friendly insulin delivery systems, such as disposable insulin pumps, that offer simplicity and convenience.  Consequently, the demand for such solutions is expected to rise as healthcare providers aim to enhance the quality of life for older adults living with diabetes, ultimately driving the market.

Opportunities

• Rising Technological Advancements

Technological advancements in disposable insulin pump technology are significantly enhancing patient experiences through the incorporation of smart features such as remote monitoring and automated insulin delivery systems. For instance, the Medtronic MiniMed 770G system integrates continuous glucose monitoring (CGM) with an insulin pump, allowing for automated insulin delivery adjustments based on real-time glucose readings. This closed-loop system simplifies diabetes management for patients and helps maintain optimal glucose levels, reducing the risk of hypoglycemia. Furthermore, companies that focus on developing advanced algorithms and connectivity features, such as those that enable seamless integration with mobile applications, are poised to capitalize on this trend. As technology continues to evolve, these innovations represent substantial opportunities for companies to improve diabetes management and enhance patient adherence to treatment protocols.

• Increasing Healthcare Expenditure

Increased healthcare expenditure, especially in developed regions, plays a crucial role in fostering the adoption of advanced medical devices, such as disposable insulin pumps. According to the Centers for Medicare & Medicaid Services (CMS), U.S. healthcare spending is projected to grow at an average rate of 5.4% annually, reaching approximately USD 6 trillion by 2027. Such surge in investment enhances access to innovative diabetes management solutions, as healthcare systems prioritize funding for technologies that improve patient outcomes and streamline care. For instance, initiatives that reimburse patients for the use of modern insulin delivery systems, including disposable insulin pumps, are becoming more common, allowing for broader access among diabetic patients. As a result, the growth in healthcare expenditure is directly correlated with improved access to effective diabetes care solutions, ultimately creating opportunities in the market.

Restraints/Challenges

• High Equipment Costs

The high cost of disposable insulin pumps serves as a significant market challenge, particularly for patients in regions with limited insurance coverage or considerable out-of-pocket expenses. As disposable insulin pumps can be prohibitively expensive, they become inaccessible to individuals with lower incomes or inadequate insurance plans. Consequently, many patients may opt for less expensive alternatives, such as traditional insulin syringes or pens, which, although effective, fail to provide the same level of convenience and efficiency in diabetes management. Such financial burden hinders the adoption of advanced insulin delivery systems and contributes to poorer health outcomes, as individuals unable to afford these technologies may struggle to maintain optimal blood glucose levels, thereby increasing their risk of diabetes-related complications.

• Limited Equipment Awareness

Limited awareness of disposable insulin pumps presents a notable challenge in their adoption, as both patients and healthcare providers may not fully understand the availability and benefits of these innovative devices. Despite their advantages, such as ease of use and improved diabetes management, many individuals continue to rely on traditional methods due to a lack of information. Such gap in awareness can result in missed opportunities for better glycemic control and overall health outcomes, as patients may struggle with the more cumbersome traditional methods. In addition, healthcare providers in these areas may not prioritize educating their patients about the latest technologies, further hampering the overall market expansion.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Disposable Insulin Pumps Market Scope

The market is segmented on the basis of type, products, accesories and end-users. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Patch pumps
• Tethered pumps

Product

• MiniMed
• Accu-Chek
• Tandem
• Omnipod
• others

Accessories

• Insulin Eeservoir or Cartridges
• Insulin Set Insertion Devices
• Battery

End-Users

• Hospitals and Clinics
• Home Care
• Laboratories

Disposable Insulin Pumps Market Regional Analysis

The market is analysed and market size insights and trends are provided by country, type, products, accesories and end-users as referenced above.

The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America stands out as the leading region in the market, primarily due to its well-established healthcare and medical facilities that ensure comprehensive patient care. The presence of major medical manufacturers and key players further enhances the region's dominance, facilitating innovation and access to advanced medical technologies. In addition, high healthcare expenditure in North America supports ongoing research and development, driving growth in the medical market.

Asia-Pacific region is projected to experience substantial growth during the forecast period from 2024 to 2031, largely driven by the rising prevalence of diabetes. As lifestyle changes and an aging population contribute to increasing diabetes rates, there is a growing demand for effective management and treatment solutions. This surge in demand is prompting healthcare providers and stakeholders in the region to invest in innovative diabetes care technologies and services, further fueling market expansion.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.  

Disposable Insulin Pumps Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Disposable Insulin Pumps Market Leaders Operating in the Market Are:

• Medtronic (U.S.)
• Insulet Corporation (U.S.)
• F. Hoffmann-La Roche Ltd (Switzerland)
• SOOIL Developments Co., Ltd (South Korea)
• Tandem Diabetes Care, Inc. (U.S.)
• SHINMYUNG MEDIYES CO., LTD. (South Korea)
• Debiotech SA (Switzerland)
• TOP Corporation (Japan)
• Kingfa Sci.&Tech. Co., Ltd (China)
• Sphere Fluidics (U.K.)
• Medsolve (UK) Limited (U.K.)
• Sanofi (France)
• Abbott (U.S.)
• BD (U.S.)

Latest Developments in Disposable Insulin Pumps Market

• 2024년 9월, 인슐린 투여 분야에서 100년의 역사를 가진 당뇨병 치료 분야의 글로벌 리더인 Embecta Corp.는 혁신적인 일회용 인슐린 투여 시스템에 대해 미국 식품의약국(FDA)으로부터 510(k) 승인을 받았다고 발표했습니다. 1형(T1D)과 2형(T2D)을 포함한 당뇨병을 관리하는 성인을 위해 설계된 이 시스템은 2형 당뇨병 환자와 의료 서비스 제공자의 통찰력을 바탕으로 개발된 300유닛 인슐린 저장소가 장착된 튜브리스 패치 펌프 디자인을 특징으로 합니다.
• 2024년 3월, FDA는 twiist 자동 인슐린 투여(AID) 시스템을 승인하여 Tidepool Loop와 통합된 최초의 인슐린 펌프로 지정했습니다. 6세 이상의 1형 당뇨병 환자를 대상으로 승인된 twiist AID 시스템은 Tidepool Loop와 함께 정밀한 마이크로도징 기능을 제공하고, 사용자가 87mg/dL만큼 낮은 목표를 설정할 수 있으며, 다양한 식품 유형에 따라 볼루징 옵션을 제공합니다.
• 2024년 1월, 의료 기술 분야의 글로벌 선두 주자인 Medtronic plc는 MiniMed™ 780G 시스템에 대한 CE(Conformité Européenne) 마크 승인을 받았다고 발표했습니다. 이 시스템에는 손가락 찌르기나 오버테이프가 필요 없는 일회용 올인원 연속 포도당 모니터(CGM)인 Simplera Sync가 포함됩니다. Simplera Sync는 간단한 2단계 삽입 과정으로 향상된 사용자 경험을 제공하며 이전 Medtronic 센서의 절반 크기입니다.
• 2023년 12월, Medtronic은 현재 Insulet과 특허 분쟁에 연루된 인슐린 패치 펌프를 제조하는 회사인 EOFlow를 인수하려는 계획을 취소했습니다. Medtronic은 두 회사 간의 계약에 대한 "여러 번의 위반"을 결정 이유로 들었습니다. 올해 EOFlow는 Insulet과 지속적인 특허 소송에 직면했습니다.
• 2023년 5월, Embecta는 당뇨병 관리를 개선하도록 설계된 혁신적인 인슐린 펌프의 개발을 위해 Tidepool과 협력했습니다. 이 전략적 제휴는 첨단 기술과 사용자 친화적인 기능을 장치에 통합하여 환자 결과를 개선하는 것을 목표로 합니다. 또한 Embecta는 제품 파이프라인과 시장 수요에 대한 확신을 반영하여 2분기 성장 전망을 높였습니다.

SKU-63894